Correlation between hypoxia inducible factor and hepcidin in maintenance hemodialysis patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044263

Enrollment

Unknown

Registered

2021-03-13

Start date

2017-01-01

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic renal failure

Interventions

maintenance hemodialysis patients:HDF+HD

Healthy control group:NO

Eligibility

Sex/Gender

All

Age

18 Years to 78 Years

Inclusion criteria

Inclusion criteria: Over 6 months of hemodialysis treatment, the general condition is stable; age > 18-years-old; according to the guidelines of Kidney Disease: Improving Global Outcomes(KDIGO) and Chinese expert consensus on the diagnosis and treatment of renal anemia (revised version 2018) 2, 4. Anemia can be diagnosed(male hemoglobin < 130 g/L, non-pregnant female hemoglobin < 120 g/L). A total of 72 patients with hemoglobin levels < 110 g were included

Exclusion criteria

Exclusion criteria: Severe heart failure; acute infection; liver disease; malignant tumor or hematological diseases; active tuberculosis; immunosuppressive agents for active inflammatory diseases; intravenous iron; gastrointestinal bleeding, blood transfusion or hospitalization for any reason in recent 3 months; peritoneal dialysis, kidney transplantation to hemodialysis (HD); unwilling to participate in research.

Design outcomes

Primary

Measure	Time frame
HIF;Hepcidin;	—

Countries

China

Contacts

Public ContactXu Jian

The First People's Hospital of Yunnan Province

xujian3979@sina.com+86 13888896697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026